Rahmouni Eya, Romdhane Racha Ben, Boukhris Sabrine, Mansouri Houyem, Henchiri Houda, Achouri Leila
Department of Surgical Oncology, Regional Hospital of Jendouba, Jendouba, Tunisia.
Department of Surgical Oncology, Regional Hospital of Jendouba, Jendouba, Tunisia.
Int J Surg Case Rep. 2025 Jan;126:110762. doi: 10.1016/j.ijscr.2024.110762. Epub 2024 Dec 24.
Rosai-Dorfman disease (RDD) is a rare histiocytic neoplasm. It most commonly presents with bilateral cervical lymphadenopathy. We report the fourth case in the literature of RDD presenting as isolated axillary lymphadenopathy.
We report the case of a 55-year-old female patient who presented with right axillary lymphadenopathy that had persisted for 1 year, without other associated symptoms. Physical examination revealed an isolated right axillary lymphadenopathy. An excisional biopsy of the lymph node was performed, and histopathological findings were consistent with Rosai-Dorfman's disease. Regular follow-up was recommended.
RDD is an uncommon histiocytic disorder. Initially identified in the 1960s as a benign, self-limited condition, RDD is now classified as a neoplastic disorder with causative mutations in the MAPK pathway. The classic presentation involves extensive, painless bilateral cervical lymphadenopathy. Isolated axillary lymph node involvement, as seen in our patient, is a rare presentation of nodal RDD with only three cases reported in the literature to date. Histologically, RDD is characterized by a prominent histiocytic infiltrate set against a background of inflammatory cells, primarily composed of lymphocytes and plasma cells. These histiocytes are typically hypochromatic, with abundant pale cytoplasm, and exhibit varying degrees of emperipolesis. In 2018, consensus guidelines for the management and evaluation of RDD were introduced.
Recent advances in genetic sequencing have reclassified RDD from a benign inflammatory disorder to a histiocytic neoplasm. Further research is needed to fully understand its implications for prognosis and treatment strategies.
罗萨伊-多夫曼病(RDD)是一种罕见的组织细胞肿瘤。它最常见的表现是双侧颈部淋巴结病。我们报告了文献中第四例表现为孤立性腋窝淋巴结病的RDD病例。
我们报告了一名55岁女性患者的病例,该患者右腋窝淋巴结病持续1年,无其他相关症状。体格检查发现孤立性右腋窝淋巴结病。对淋巴结进行了切除活检,组织病理学结果与罗萨伊-多夫曼病一致。建议定期随访。
RDD是一种罕见的组织细胞疾病。RDD最初在20世纪60年代被确定为一种良性的自限性疾病,现在被归类为一种在丝裂原活化蛋白激酶(MAPK)途径中有致病突变的肿瘤性疾病。典型表现包括广泛的、无痛性双侧颈部淋巴结病。如我们患者所见的孤立性腋窝淋巴结受累是结节性RDD的罕见表现,迄今为止文献中仅报道了3例。在组织学上,RDD的特征是在以淋巴细胞和浆细胞为主的炎症细胞背景下有突出的组织细胞浸润。这些组织细胞通常是低色素性的,有丰富的淡染细胞质,并表现出不同程度的血细胞吞噬现象。2018年,引入了RDD管理和评估的共识指南。
基因测序的最新进展已将RDD从良性炎症性疾病重新分类为组织细胞肿瘤。需要进一步研究以充分了解其对预后和治疗策略的影响。